Search by Drug Name or NDC
NDC 51672-1403-04 Clindamycin Phosphate and Benzoyl Peroxide 50; 10 mg/g; mg/g Details
Clindamycin Phosphate and Benzoyl Peroxide 50; 10 mg/g; mg/g
Clindamycin Phosphate and Benzoyl Peroxide is a TOPICAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Taro Pharmaceuticals U.S.A., Inc.. The primary component is BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE.
Product Information
| NDC | 51672-1403 |
|---|---|
| Product ID | 51672-1403_cd255027-9e43-41a2-b161-8110796e7f5a |
| Associated GPIs | |
| GCN Sequence Number | 073195 |
| GCN Sequence Number Description | clindamycin phos/benzoyl perox GEL W/PUMP 1.2%-3.75% TOPICAL |
| HIC3 | L5H |
| HIC3 Description | ACNE AGENTS,TOPICAL |
| GCN | 37564 |
| HICL Sequence Number | 017263 |
| HICL Sequence Number Description | CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE |
| Brand/Generic | Generic |
| Proprietary Name | Clindamycin Phosphate and Benzoyl Peroxide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Clindamycin Phosphate and Benzoyl Peroxide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | GEL |
| Route | TOPICAL |
| Active Ingredient Strength | 50; 10 |
| Active Ingredient Units | mg/g; mg/g |
| Substance Name | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Pharmaceutical Class | Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA208683 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51672-1403-04 (51672140304)
| NDC Package Code | 51672-1403-4 |
|---|---|
| Billing NDC | 51672140304 |
| Package | 50 g in 1 BOTTLE, PUMP (51672-1403-4) |
| Marketing Start Date | 2018-06-05 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 6.07 |
| Pricing Unit | GM |
| Effective Date | 2024-01-17 |
| NDC Description | CLINDAMYC-BNZ PEROX 1.2-3.75% |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis